WuXi Biologics (Cayman) Inc. (2269) Schedules Board Meeting to Review 2025 Annual Results

Bulletin Express
02/11

WuXi Biologics (Cayman) Inc. (2269) announced that its Board of Directors will convene on March 24, 2026. The purpose of this meeting is to consider and approve the annual results for the year ended December 31, 2025, as well as to address other related matters.

According to the announcement dated February 11, 2026, the Board currently comprises executive, non-executive, and independent non-executive directors, with Dr. Ge Li serving as Chairman.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10